{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:51:49Z","timestamp":1794264709824,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.urolonc.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T01:36:21Z","timestamp":1671068181000},"page":"274-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review"],"prefix":"10.1016","volume":"41","author":[{"given":"Sofia","family":"Fontanet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Territo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Gavrilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Palou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2022.11.001_bib0001","first-page":"1","article-title":"The prognostic impact of tumor architecture for upper urinary tract urothelial carcinoma: a propensity score-weighted analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2022.11.001_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/547586","article-title":"Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancers","volume":"2015","author":"Gillan","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.001_bib0003","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.urology.2006.05.040","article-title":"Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tract","volume":"68","author":"Yuasa","year":"2006","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0004","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.eururo.2008.04.083","article-title":"Carcinoma in situ of the upper urinary tract treated with radical nephroureterectomy \u2013 results from a multicenter study","volume":"54","author":"Karam","year":"2008","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.juro.2017.10.019","article-title":"Biological behavior and long-term outcomes of carcinoma in situ in upper urinary tract managed by radical nephroureterectomy","volume":"199","author":"Inamoto","year":"2018","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.001_bib0006","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.001_bib0007","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-5347(17)47277-6","article-title":"Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin","volume":"134","author":"Herr","year":"1985","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0008","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0022-5347(17)38957-7","article-title":"Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ","volume":"142","author":"Studer","year":"1989","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.001_bib0009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)36117-7","article-title":"Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ","volume":"149","author":"Sharpe","year":"1993","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.001_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1464-410X.1996.09559.x","article-title":"Bacillus Calmette-Gu\u00e9rin perfusion therapy for carcinoma in situ of the upper urinary tract","volume":"77","author":"Yokogi","year":"1996","journal-title":"Br J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.001_bib0011","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1159\/000020365","article-title":"Bacillus Calmette-Guerin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract","volume":"38","author":"Nonomura","year":"2000","journal-title":"Eur Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.001_bib0012","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1464-410x.2000.00610.x","article-title":"Bacillus Calmette-Guerin instillation treatment for carcinoma in situ of the upper urinary tract","volume":"85","author":"Nishino","year":"2000","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.001_bib0013","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1442-2042.2002.00551.x","article-title":"Clinical outcome of bacillus Calmette-Gu\u00e9rin perfusion therapy for carcinoma in situ of the upper urinary tract","volume":"9","author":"Miyake","year":"2002","journal-title":"Int J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.001_bib0014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","article-title":"Intravesical instillation of bacille Calmette-Gu\u00e9rin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter","volume":"59","author":"Irie","year":"2002","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.001_bib0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","article-title":"Long-term effects of bacille calmette-gu\u00e9rin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract","volume":"63","author":"Hayashida","year":"2004","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0016","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","article-title":"Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Gu\u00e9rin therapy","volume":"13","author":"Kojima","year":"2006","journal-title":"Int J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.001_bib0017","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","article-title":"Antegrade perfusion with bacillus calmette-Gu\u00e9rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?","volume":"60","author":"Giannarini","year":"2011","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.001_bib0018","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/07357907.2018.1430815","article-title":"Efficacy and tolerability of bacillus Calmette-Gu\u00e9rin therapy as the first-line therapy for upper urinary tract carcinoma in situ","volume":"36","author":"Tomisaki","year":"2018","journal-title":"Cancer Invest"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-018-1102-y","article-title":"Impact of bacillus Calmette\u2013Gu\u00e9rin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy","volume":"35","author":"Horiguchi","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.urolonc.2022.11.001_bib0020","first-page":"372","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.001_bib0021","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00345-018-2349-9","article-title":"Salvage topical therapy for upper tract urothelial carcinoma","volume":"36","author":"Balasubramanian","year":"2018","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.001_bib0022","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1464-410X.2002.t01-9-02731.x","article-title":"Intrarenal bacillus Calmette-Gu\u00e9rin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure","volume":"89","author":"Kawakami","year":"2002","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.001_bib0023","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.juro.2016.03.194","article-title":"Upper urinary tract carcinoma in situ: current knowledge, future direction","volume":"197","author":"Redrow","year":"2017","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.001_bib0024","first-page":"430","article-title":"Endocavitary treatment for upper tract urothelial carcinoma: a meta-analysis of the current literature","volume":"37","author":"Foerster","year":"2019","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"2 Part 1","key":"10.1016\/j.urolonc.2022.11.001_bib0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0022-5347(17)36572-2","article-title":"The double-j ureteral stent: in vivo and in vitro flow studies","volume":"148","author":"H\u00fcbner","year":"1992","journal-title":"J Urol [Internet]"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.001_bib0026","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1089\/end.2012.0229","article-title":"Outcomes of intrarenal Bacillus Calmette-Gu\u00e9rin\/Interferon-\u03b12B for Biopsy-Proven Upper-Tract Carcinoma in Situ","volume":"26","author":"Shapiro","year":"2012","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.001_bib0027","first-page":"175","article-title":"[Intrarenal Bacillus Calmette-Guerin perfusion therapy was effective for carcinoma in situ of the upper urinary tract after ileal conduit replacement\u202f: a case report]","volume":"60","author":"Hayashi","year":"2014","journal-title":"Hinyokika Kiyo"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.001_bib0028","first-page":"573","article-title":"The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis]","volume":"52","author":"Saito","year":"2006","journal-title":"Hinyokika Kiyo"},{"issue":"9","key":"10.1016\/j.urolonc.2022.11.001_bib0029","first-page":"443","article-title":"A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder","volume":"60","author":"Obayashi","year":"2014","journal-title":"Hinyokika Kiyo I"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.001_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/iju.12268","article-title":"Bacillus Calmette-Gu\u00e9rin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy","volume":"21","author":"Yamashita","year":"2014","journal-title":"Int J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:08Z","timestamp":1761042368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1078143922004343"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical instillation of BCG immunotherapy for biopsy-proven primary upper urinary tract carcinoma in situ: A single institution series and systematic review","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}